Table 3 Demographic and operative data, and the use of other blood component products in patients who were administered massive RBC transfusion (≥10 units)

Males/females

33/15 (69/31)

Mean age ± SD (range)

48 ± 16 (34 – 90)

ASA^a I

2 (4.2)

   II

7 (15)

   III

13 (27)

   IV

14 (29)

   V

7 (15)

OC/LC

39/9 (81/19)

Elective/emergency^b

13/34 (28/72)

Mean operative time ± SD (min)

122 ± 74

Intraoperative cholangiography

8 (17)

Common bile duct exploration

6 (13)

Proportion of patients with PTL transfusion

22 (46)

Proportion of patients with FFP transfusion

30 (63)

Proportion of patients with Octaplas® transfusion

7 (15)

In-hospital mortality

7 (15)

Length of hospital stay ± SD (d)

23 ± 14